A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction

The increase in coronavirus disease 2019 (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed pressure on healthcare services worldwide. Therefore, it is crucial to identify critical factors for the assessment of the severity of COVID-19 infection an...

Full description

Bibliographic Details
Main Authors: Asif Hassan Syed, Tabrej Khan, Nashwan Alromema
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/7/1604
_version_ 1827624075494686720
author Asif Hassan Syed
Tabrej Khan
Nashwan Alromema
author_facet Asif Hassan Syed
Tabrej Khan
Nashwan Alromema
author_sort Asif Hassan Syed
collection DOAJ
description The increase in coronavirus disease 2019 (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed pressure on healthcare services worldwide. Therefore, it is crucial to identify critical factors for the assessment of the severity of COVID-19 infection and the optimization of an individual treatment strategy. In this regard, the present study leverages a dataset of blood samples from 485 COVID-19 individuals in the region of Wuhan, China to identify essential blood biomarkers that predict the mortality of COVID-19 individuals. For this purpose, a hybrid of filter, statistical, and heuristic-based feature selection approach was used to select the best subset of informative features. As a result, minimum redundancy maximum relevance (mRMR), a two-tailed unpaired <i>t</i>-test, and whale optimization algorithm (WOA) were eventually selected as the three most informative blood biomarkers: International normalized ratio (INR), platelet large cell ratio (P-LCR), and D-dimer. In addition, various machine learning (ML) algorithms (random forest (RF), support vector machine (SVM), extreme gradient boosting (EGB), naïve Bayes (NB), logistic regression (LR), and k-nearest neighbor (KNN)) were trained. The performance of the trained models was compared to determine the model that assist in predicting the mortality of COVID-19 individuals with higher accuracy, F1 score, and area under the curve (AUC) values. In this paper, the best performing RF-based model built using the three most informative blood parameters predicts the mortality of COVID-19 individuals with an accuracy of 0.96 ± 0.062, F1 score of 0.96 ± 0.099, and AUC value of 0.98 ± 0.024, respectively on the independent test data. Furthermore, the performance of our proposed RF-based model in terms of accuracy, F1 score, and AUC was significantly better than the known blood biomarkers-based ML models built using the Pre_Surv_COVID_19 data. Therefore, the present study provides a novel hybrid approach to screen the most informative blood biomarkers to develop an RF-based model, which accurately and reliably predicts in-hospital mortality of confirmed COVID-19 individuals, during surge periods. An application based on our proposed model was implemented and deployed at Heroku.
first_indexed 2024-03-09T12:01:46Z
format Article
id doaj.art-831ad41f09ac4f1ea1052b747fd788e8
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T12:01:46Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-831ad41f09ac4f1ea1052b747fd788e82023-11-30T23:03:10ZengMDPI AGDiagnostics2075-44182022-06-01127160410.3390/diagnostics12071604A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality PredictionAsif Hassan Syed0Tabrej Khan1Nashwan Alromema2Department of Computer Science, Faculty of Computing and Information Technology Rabigh (FCITR), King Abdulaziz University, Jeddah 22254, Saudi ArabiaDepartment of Information Systems, Faculty of Computing and Information Technology Rabigh (FCITR), King Abdulaziz University, Jeddah 22254, Saudi ArabiaDepartment of Computer Science, Faculty of Computing and Information Technology Rabigh (FCITR), King Abdulaziz University, Jeddah 22254, Saudi ArabiaThe increase in coronavirus disease 2019 (COVID-19) infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed pressure on healthcare services worldwide. Therefore, it is crucial to identify critical factors for the assessment of the severity of COVID-19 infection and the optimization of an individual treatment strategy. In this regard, the present study leverages a dataset of blood samples from 485 COVID-19 individuals in the region of Wuhan, China to identify essential blood biomarkers that predict the mortality of COVID-19 individuals. For this purpose, a hybrid of filter, statistical, and heuristic-based feature selection approach was used to select the best subset of informative features. As a result, minimum redundancy maximum relevance (mRMR), a two-tailed unpaired <i>t</i>-test, and whale optimization algorithm (WOA) were eventually selected as the three most informative blood biomarkers: International normalized ratio (INR), platelet large cell ratio (P-LCR), and D-dimer. In addition, various machine learning (ML) algorithms (random forest (RF), support vector machine (SVM), extreme gradient boosting (EGB), naïve Bayes (NB), logistic regression (LR), and k-nearest neighbor (KNN)) were trained. The performance of the trained models was compared to determine the model that assist in predicting the mortality of COVID-19 individuals with higher accuracy, F1 score, and area under the curve (AUC) values. In this paper, the best performing RF-based model built using the three most informative blood parameters predicts the mortality of COVID-19 individuals with an accuracy of 0.96 ± 0.062, F1 score of 0.96 ± 0.099, and AUC value of 0.98 ± 0.024, respectively on the independent test data. Furthermore, the performance of our proposed RF-based model in terms of accuracy, F1 score, and AUC was significantly better than the known blood biomarkers-based ML models built using the Pre_Surv_COVID_19 data. Therefore, the present study provides a novel hybrid approach to screen the most informative blood biomarkers to develop an RF-based model, which accurately and reliably predicts in-hospital mortality of confirmed COVID-19 individuals, during surge periods. An application based on our proposed model was implemented and deployed at Heroku.https://www.mdpi.com/2075-4418/12/7/1604COVID-19blood biomarkershybrid-feature selectionfilter-based feature selectiontwo-tailed unpaired <i>t</i>-testmeta-heuristic method
spellingShingle Asif Hassan Syed
Tabrej Khan
Nashwan Alromema
A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction
Diagnostics
COVID-19
blood biomarkers
hybrid-feature selection
filter-based feature selection
two-tailed unpaired <i>t</i>-test
meta-heuristic method
title A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction
title_full A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction
title_fullStr A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction
title_full_unstemmed A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction
title_short A Hybrid Feature Selection Approach to Screen a Novel Set of Blood Biomarkers for Early COVID-19 Mortality Prediction
title_sort hybrid feature selection approach to screen a novel set of blood biomarkers for early covid 19 mortality prediction
topic COVID-19
blood biomarkers
hybrid-feature selection
filter-based feature selection
two-tailed unpaired <i>t</i>-test
meta-heuristic method
url https://www.mdpi.com/2075-4418/12/7/1604
work_keys_str_mv AT asifhassansyed ahybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction
AT tabrejkhan ahybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction
AT nashwanalromema ahybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction
AT asifhassansyed hybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction
AT tabrejkhan hybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction
AT nashwanalromema hybridfeatureselectionapproachtoscreenanovelsetofbloodbiomarkersforearlycovid19mortalityprediction